Compare Quest Diagnostics Inc (DGX) vs Ishares Msci Spain ETF (EWP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Ishares Msci Spain ETF — how do they compare? Quest Diagnostics Inc trades at $237.51 (market cap $26.24B), while Ishares Msci Spain ETF trades at $63.39. The key difference: Quest Diagnostics Inc pays a 1.45% dividend while Ishares Msci Spain ETF pays none. Which is the better fit depends on your goals.
| DGX | EWP | |
|---|---|---|
Market Cap | $26.24B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $238.50 | $62.80 |
52-Week Low | $173.49 | $47.02 |
Enterprise Value | $32.00B | — |
Dividend Yield | 1.45% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $237.99, up 0.15% on the day, near its 52-week high. The stock shows strong momentum with consecutive earnings beats in 2026, including Q2 EPS of $3.12 versus $2.82 expected. Revenue growth accelerated to $11.04 billion in 2025, with net income margin at 9.19%. Technical indicators signal a bullish trend, while analyst consensus is a $249.50 price target. Recent news highlights AI integration and raised 2026 outlook amid robust testing demand.
The outlook for DGX is positive, driven by earnings momentum, strategic partnerships, and healthcare demand. Investment opportunity lies in sustained growth and dividend yield, but risks include margin pressure from lower-margin deals and high debt levels. Valuation at a P/E of 25.21 requires continued execution to justify upside.
EWP shares trade at $62.80, up 0.62% with a bullish technical bias from moving averages but overbought RSI signals. The stock shows strong institutional support with 17 buy signals versus 7 sells. Recent dividend declaration of $0.92 per share for H1-2026 indicates management's confidence in cash flow stability. European market exposure provides diversification benefits amid U.S. market volatility.
Outlook remains cautiously optimistic given technical strength and dividend commitment, though valuation metrics are unavailable for fundamental assessment. Key risks include European economic sensitivity and currency fluctuations. The stock's proximity to resistance at $63 requires monitoring for breakout confirmation or pullback opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Ishares Msci Spain ETF
EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.
Read more on EWP →
